NCT04077359 (PROTEHCT) is a NA clinical trial of CT in Urothelial Carcinoma, sponsored by Oslo University Hospital.

Who is sponsoring NCT04077359?

NCT04077359 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT04077359?

Interventions in NCT04077359: CT.

What condition does NCT04077359 study?

NCT04077359 studies Urothelial Carcinoma, Renal Cell Carcinoma, Renal Cyst, Renal Stone.

Is NCT04077359 still recruiting?

NCT04077359 is currently completed. Last updated 6 September 2022.

Last reviewed 2022-09-06 · How we verify

NCT04077359: PROTEHCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Trial for Examining Hematuria Using Computed Tomography

Completed NA Last updated 6 September 2022

What this trial tests

NA trial testing CT in Urothelial Carcinoma in 300 participants. Completed in 1 July 2021.

Timeline

15 September 2019

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	300
Start date	15 September 2019
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across Norway

Drugs / interventions tested

Conditions studied

Urothelial Carcinoma — all drugs for Urothelial Carcinoma →
Renal Cell Carcinoma — all drugs for Renal Cell Carcinoma →
Renal Cyst — all drugs for Renal Cyst →
Renal Stone — all drugs for Renal Stone →

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Urothelial Carcinoma or Renal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to evaluate whether one-phase nephrographic CT (experimental) is sufficient to detect urothelial cell carcinoma in patients with hematuria compared to the traditional four-phase CT (control).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison.
Galtung KF, Lauritzen PM, Sandbæk G, Bay D, et al · · 2023 · cited 8× · PMID 37693732 · DOI 10.1016/j.euros.2023.06.005

Verify or expand the search:

Other trials of CT

Trials testing the same drug.

NCT06308094 — 320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation · NA · recruiting
NCT06696677 — Small Intestine Length Measurement Using 3D CT Volumetry and in Vivo Measurement Using Pre-marked Graspers in Revisional · NA · recruiting
NCT06537193 — Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment · NA · recruiting
NCT06597877 — CT Temporal Bone Anatomical Variations · not yet recruiting
NCT06081855 — Predictors of Aortic Root Dilatation in Tetralogy of Fallot Patients · unknown

Other recruiting trials for Urothelial Carcinoma

Currently open trials in the same condition.

NCT07416123 — A Study of GEN1106 in Participants With Solid Tumors · Phase 1 · recruiting
NCT07322263 — Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC · Phase 2 · recruiting
NCT07421700 — Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, PHASE2 · recruiting
NCT07492628 — Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma · Phase 1 · recruiting
NCT07390617 — A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04077359 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 6 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04077359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing